We are live on ! Find out more
MIM

Marco Investment Management Portfolio holdings

AUM $1.52B
1-Year Est. Return 47.33%
This Fund
S&P 500
This Quarter Est. Return
+4.52%
1 Year Est. Return
+47.33%
3 Year Est. Return
+126.67%
5 Year Est. Return
+163.42%
10 Year Est. Return
+512.74%
AUM
$589M
AUM Growth
+$15.3M
Cap. Flow
-$6.69M
Cap. Flow %
-1.14%
Top 10 Hldgs %
26.02%
Holding
187
New
3
Increased
45
Reduced
81
Closed
10

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$3.14M
2
QCOM icon
Qualcomm
QCOM
+$2.43M
3
VZ icon
Verizon
VZ
+$1.3M
4
AAL icon
American Airlines Group
AAL
+$1.15M
5
MBLY
Mobileye N.V.
MBLY
+$1,000K

Sector Composition

Rank Sector Weight
1 Technology 18.27%
2 Healthcare 18.04%
3 Financials 12.48%
4 Industrials 10.69%
5 Consumer Staples 9.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LLL
51
DELISTED
L3 Technologies, Inc.
LLL
$3.62M 0.61%
21,895
-50
-0.2% -$8.09K
O icon
52
Realty Income
O
$54.1B
$3.53M 0.6%
61,173
+10,737
+21% +$622K
D icon
53
Dominion Energy
D
$55.9B
$3.45M 0.59%
44,450
-1,065
-2% -$80.6K
MON
54
DELISTED
Monsanto Co
MON
$3.37M 0.57%
29,741
GPC icon
55
Genuine Parts
GPC
$18B
$3.35M 0.57%
36,264
ETN icon
56
Eaton
ETN
$155B
$3.28M 0.56%
44,190
-1,600
-3% -$114K
C icon
57
Citigroup
C
$223B
$3.21M 0.54%
53,591
+3,068
+6% +$181K
MNDT
58
DELISTED
Mandiant, Inc. Common Stock
MNDT
$3.16M 0.54%
250,600
-36,700
-13% -$438K
BNY
59
Bank of New York Mellon
BNY
$104B
$3.03M 0.51%
64,100
AYI icon
60
Acuity Brands
AYI
$8.89B
$2.96M 0.5%
14,510
+10
+0.1% +$2.11K
EXPE icon
61
Expedia Group
EXPE
$34.4B
$2.9M 0.49%
23,023
-400
-2% -$48.8K
GOOGL icon
62
Alphabet (Google) Class A
GOOGL
$4.19T
$2.88M 0.49%
67,860
+14,720
+28% +$619K
BAC icon
63
Bank of America
BAC
$405B
$2.85M 0.48%
120,935
-7,985
-6% -$189K
GIS icon
64
General Mills
GIS
$19.7B
$2.77M 0.47%
46,899
-2,200
-4% -$134K
HON icon
65
Honeywell
HON
$65.8B
$2.69M 0.46%
23,804
+1,448
+6% +$160K
TTE icon
66
TotalEnergies
TTE
$201B
$2.63M 0.45%
52,260
+2,200
+4% +$111K
IBM icon
67
IBM
IBM
$224B
$2.62M 0.44%
15,699
-210
-1% -$35.2K
T icon
68
AT&T
T
$177B
$2.56M 0.44%
81,727
-781
-0.9% -$24.6K
STI
69
DELISTED
SunTrust Banks, Inc.
STI
$2.52M 0.43%
45,535
-2,100
-4% -$120K
NVS icon
70
Novartis
NVS
$264B
$2.43M 0.41%
36,566
+447
+1% +$29.8K
ACN icon
71
Accenture
ACN
$116B
$2.39M 0.41%
19,900
-600
-3% -$71.6K
MCD icon
72
McDonald's
MCD
$176B
$2.21M 0.38%
17,074
+4
+0% +$502
VNQ icon
73
Vanguard Real Estate ETF
VNQ
$36.9B
$2.1M 0.36%
25,425
+25
+0.1% +$2.07K
TMO icon
74
Thermo Fisher Scientific
TMO
$240B
$2.06M 0.35%
13,880
SLB icon
75
SLB Ltd
SLB
$77.6B
$1.98M 0.34%
25,304
-1,000
-4% -$81.8K

Similar funds

Marco Investment Management's Q1 2017 Portfolio in Review

As of Q1 2017, Marco Investment Management held 187 positions worth $589M, up 2.7% from $574M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Marco Investment Management's Q1 2017 filing shows 3 new, 45 increased, 81 reduced and 10 closed positions. Its largest new stake was State Street Health Care Select Sector SPDR ETF: 3,370 shares worth $251K. The largest sale was Johnson Controls International, an estimated $3.95M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Marco Investment Management's largest Q1 2017 buy was State Street Health Care Select Sector SPDR ETF: 3,370 shares worth $251K.
  • Marco Investment Management added most to Gilead Sciences in Q1 2017, an estimated $3.14M increase.
  • Marco Investment Management's biggest Q1 2017 reduction was AGCO, cutting an estimated $2.55M.
  • Marco Investment Management fully exited Johnson Controls International in Q1 2017, selling an estimated $3.95M.
  • Marco Investment Management's ten largest holdings make up 26% of its $589M portfolio in Q1 2017.
  • Marco Investment Management opened 3 new positions and closed 10 in Q1 2017.
  • Marco Investment Management's portfolio value rose 2.7% quarter-over-quarter to $589M.

Based on Marco Investment Management's 13F filing for Q1 2017, filed 12 May 2017.